Clinical trial

Efficacy of a Streamlined Heart Failure Optimization Protocol

NCT05021419

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-07-17

PhaseNA

Study timeline

Study start (actual)2022-07-17Date precision: day

Registry last updated2025-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure with Reduced Ejection Fractionunresolved

Chronic Heart Failureunresolved

Interventions

Streamlined protocolOTHER

Standard ProtocolOTHER

Sponsors & collaborators

The Queen Elizabeth Hospital King's Lynn NHS Foundation Trustlead sponsor

Novartis Pharmaceuticalscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05021419 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.